Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
Link to record
Permanent link

Direct link
Rosenling, Therese
Publications (8 of 8) Show all publications
Hopfgarten, J., Stenwall, P.-A., Wiberg, A., Anagandula, M., Ingvast, S., Rosenling, T., . . . Skog, O. (2014). Gene expression analysis of human islets in a subject at onset of type 1 diabetes. Acta Diabetologica, 51(2), 199-204
Open this publication in new window or tab >>Gene expression analysis of human islets in a subject at onset of type 1 diabetes
Show others...
2014 (English)In: Acta Diabetologica, ISSN 0940-5429, E-ISSN 1432-5233, Vol. 51, no 2, p. 199-204Article in journal (Refereed) Published
Abstract [en]

Swollen islet cells have been repeatedly described at onset of type 1 diabetes, but the underlying mechanism of this observation, termed hydropic degeneration, awaits characterization. In this study, laser capture microdissection was applied to extract the islets from an organ donor that died at onset of type 1 diabetes and from an organ donor without pancreatic disease. Morphologic analysis revealed extensive hydropic degeneration in 73 % of the islets from the donor with type 1 diabetes. Expression levels of genes involved in apoptosis, ER stress, beta cell function, and inflammation were analyzed in isolated and laser-captured islets by qPCR. The chemokine MCP-1 was expressed in islets from the donor with type 1 diabetes while undetectable in the control donor. No other signs of inflammation were detected. There were no signs of apoptosis on the gene expression level, which was also confirmed by negative immunostaining for cleaved caspase-8. There was an increased expression of the transcription factor ATF4, involved in transcription of ER stress genes, in the diabetic islets, but no further signs of ER stress were identified. In summary, on the transcription level, islets at onset of type 1 diabetes in which many beta cells display hydropic degeneration show no obvious signs of apoptosis, ER stress, or inflammation, supporting the notion that these cells are responding normally to high glucose and eventually succumbing to beta cell exhaustion. Also, this study validates the feasibility of performing qPCR analysis of RNA extracted from islets from subjects with recent onset of T1D and healthy controls by laser capture microdissection.

Place, publisher, year, edition, pages
Springer, 2014
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:uu:diva-202844 (URN)10.1007/s00592-013-0479-5 (DOI)000334054200004 ()23624551 (PubMedID)2-s2.0-84898441161 (Scopus ID)
Available from: 2013-06-28 Created: 2013-06-28 Last updated: 2026-03-04Bibliographically approved
Rosenling, T., Stoop, M., Attali, A., van Aken, H., Suidgeest, E., Christin, C., . . . Luider, T. (2012). Profiling and Identification of Cerebrospinal Fluid Proteins in a Rat EAE Model of Multiple Sclerosis.. Journal of Proteome Research, 11(4), 2048-2060
Open this publication in new window or tab >>Profiling and Identification of Cerebrospinal Fluid Proteins in a Rat EAE Model of Multiple Sclerosis.
Show others...
2012 (English)In: Journal of Proteome Research, ISSN 1535-3893, E-ISSN 1535-3907, Vol. 11, no 4, p. 2048-2060Article in journal (Refereed) Published
Abstract [en]

The experimental autoimmune encephalomyelitis (EAE) model resembles certain aspects of multiple sclerosis (MScl), with common features such as motor dysfunction, axonal degradation, and infiltration of T-cells. We studied the cerebrospinal fluid (CSF) proteome in the EAE rat model to identify proteomic changes relevant for MScl disease pathology. EAE was induced in male Lewis rats by injection of myelin basic protein (MBP) together with complete Freund's adjuvant (CFA). An inflammatory control group was injected with CFA alone, and a nontreated group served as healthy control. CSF was collected at day 10 and 14 after immunization and analyzed by bottom-up proteomics on Orbitrap LC-MS and QTOF LC-MS platforms in two independent laboratories. By combining results, 44 proteins were discovered to be significantly increased in EAE animals compared to both control groups, 25 of which have not been mentioned in relation to the EAE model before. Lysozyme C1, fetuin B, T-kininogen, serum paraoxonase/arylesterase 1, glutathione peroxidase 3, complement C3, and afamin are among the proteins significantly elevated in this rat EAE model. Two proteins, afamin and complement C3, were validated in an independent sample set using quantitative selected reaction monitoring mass spectrometry. The molecular weights of the identified differentially abundant proteins indicated an increased transport across the blood-brain barrier (BBB) at the peak of the disease, caused by an increase in BBB permeability.

Keywords
EAE, Proteomics, Multiple Sclerosis, Mass Spectrometry
National Category
Natural Sciences
Research subject
Analytical Chemistry
Identifiers
urn:nbn:se:uu:diva-173137 (URN)
Available from: 2012-04-19 Created: 2012-04-19 Last updated: 2018-06-04
Rosenling, T., Attali, A., Luider, T. M. & Bischoff, R. (2011). The experimental autoimmune encephalomyelitis model for proteomic biomarker studies: from rat to human.. Clinica Chimica Acta, 412(11-12), 812-22
Open this publication in new window or tab >>The experimental autoimmune encephalomyelitis model for proteomic biomarker studies: from rat to human.
2011 (English)In: Clinica Chimica Acta, ISSN 0009-8981, E-ISSN 1873-3492, Vol. 412, no 11-12, p. 812-22Article in journal (Refereed) Published
Abstract [en]

Multiple sclerosis (MScl) is defined by central nervous system (CNS) inflammation, demyelination and axonal damage. Some of the disease mechanisms are known but the cause of this complex disorder stays an enigma. Experimental autoimmune encephalomyelitis (EAE) is an animal model mimicking many aspects of MScl. This review aims to provide an overview over proteomic biomarker studies in the EAE model emphasizing the translational aspects with respect to MScl in humans.

National Category
Natural Sciences
Identifiers
urn:nbn:se:uu:diva-162114 (URN)10.1016/j.cca.2011.02.004 (DOI)21333641 (PubMedID)
Available from: 2011-11-24 Created: 2011-11-24 Last updated: 2017-12-08
Rosenling, T., Stoop, M. P., Smolinska, A., Muilwijk, B., Coulier, L., Shi, S., . . . Bischoff, R. (2011). The Impact of Delayed Storage on the Measured Proteome and Metabolome of Human Cerebrospinal Fluid. Clinical Chemistry, 57(12), 1703-1711
Open this publication in new window or tab >>The Impact of Delayed Storage on the Measured Proteome and Metabolome of Human Cerebrospinal Fluid
Show others...
2011 (English)In: Clinical Chemistry, ISSN 0009-9147, E-ISSN 1530-8561, Vol. 57, no 12, p. 1703-1711Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Because cerebrospinal fluid (CSF) is in close contact with diseased areas in neurological disorders, it is an important source of material in the search for molecular biomarkers. However, sample handling for CSF collected from patients in a clinical setting might not always be adequate for use in proteomics and metabolomics studies. METHODS: We left CSF for 0, 30, and 120 min at room temperature immediately after sample collection and centrifugation/removal of cells. After tryptic digestion at 2 laboratories by nanoLC Orbitrap-MS and chipLC QTOF-MS, CSF proteomes were analyzed. Metabolome analysis was performed at 3 laboratories by NMR, GC-MS, and LC-MS. Targeted analyses of cystatin C and albumin were performed by LC-MS/MS in the selected reaction monitoring mode. RESULTS: We did not find significant changes in the measured proteome and metabolome of CSF stored at room temperature after centrifugation, except for 2 peptides and 1 metabolite, 2,3,4-trihydrobutanoic acid, of 5780 identified peptides and 93 identified metabolites. A sensitive protein stability marker, cystatin C, was not affected. CONCLUSIONS: The measured proteome and metabolome of centrifuged, human CSF is stable at room temperature for up to 2 hours. We cannot exclude, however, that changes undetectable with our current methodology, such as denaturation or proteolysis, might occur due to sample handling conditions. The stability we observed gives laboratory personnel at the collection site sufficient time to aliquot samples before freezing and storage at -80 °C.

National Category
Natural Sciences
Identifiers
urn:nbn:se:uu:diva-162111 (URN)10.1373/clinchem.2011.167601 (DOI)21998343 (PubMedID)
Available from: 2011-11-24 Created: 2011-11-24 Last updated: 2017-12-08Bibliographically approved
Suits, F., Hoekman, B., Rosenling, T., Bischoff, R. & Horvatovich, P. (2011). Threshold-avoiding proteomics pipeline.. Analytical Chemistry, 83(20), 7786-94
Open this publication in new window or tab >>Threshold-avoiding proteomics pipeline.
Show others...
2011 (English)In: Analytical Chemistry, ISSN 0003-2700, E-ISSN 1520-6882, Vol. 83, no 20, p. 7786-94Article in journal (Refereed) Published
Abstract [en]

We present a new proteomics analysis pipeline focused on maximizing the dynamic range of detected molecules in liquid chromatography-mass spectrometry (LC-MS) data and accurately quantifying low-abundance peaks to identify those with biological relevance. Although there has been much work to improve the quality of data derived from LC-MS instruments, the goal of this study was to extend the dynamic range of analyzed compounds by making full use of the information available within each data set and across multiple related chromatograms in an experiment. Our aim was to distinguish low-abundance signal peaks from noise by noting their coherent behavior across multiple data sets, and central to this is the need to delay the culling of noise peaks until the final peak-matching stage of the pipeline, when peaks from a single sample appear in the context of all others. The application of thresholds that might discard signal peaks early is thereby avoided, hence the name TAPP: threshold-avoiding proteomics pipeline. TAPP focuses on quantitative low-level processing of raw LC-MS data and includes novel preprocessing, peak detection, time alignment, and cluster-based matching. We demonstrate the performance of TAPP on biologically relevant sample data consisting of porcine cerebrospinal fluid spiked over a wide range of concentrations with horse heart cytochrome c.

National Category
Natural Sciences
Identifiers
urn:nbn:se:uu:diva-162112 (URN)10.1021/ac201332j (DOI)21879761 (PubMedID)
Available from: 2011-11-24 Created: 2011-11-24 Last updated: 2017-12-08
Stoop, M. P., Coulier, L., Rosenling, T., Shi, S., Smolinska, A. M., Buydens, L., . . . Luider, T. M. (2010). Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.. Molecular & Cellular Proteomics, 9(9), 2063-75
Open this publication in new window or tab >>Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.
Show others...
2010 (English)In: Molecular & Cellular Proteomics, ISSN 1535-9476, E-ISSN 1535-9484, Vol. 9, no 9, p. 2063-75Article in journal (Refereed) Published
Abstract [en]

The analysis of cerebrospinal fluid (CSF) is used in biomarker discovery studies for various neurodegenerative central nervous system (CNS) disorders. However, little is known about variation of CSF proteins and metabolites between patients without neurological disorders. A baseline for a large number of CSF compounds appears to be lacking. To analyze the variation in CSF protein and metabolite abundances in a number of well-defined individual samples of patients undergoing routine, non-neurological surgical procedures, we determined the variation of various proteins and metabolites by multiple analytical platforms. A total of 126 common proteins were assessed for biological variations between individuals by ESI-Orbitrap. A large spread in inter-individual variation was observed (relative standard deviations [RSDs] ranged from 18 to 148%) for proteins with both high abundance and low abundance. Technical variation was between 15 and 30% for all 126 proteins. Metabolomics analysis was performed by means of GC-MS and nuclear magnetic resonance (NMR) imaging and amino acids were specifically analyzed by LC-MS/MS, resulting in the detection of more than 100 metabolites. The variation in the metabolome appears to be much more limited compared with the proteome: the observed RSDs ranged from 12 to 70%. Technical variation was less than 20% for almost all metabolites. Consequently, an understanding of the biological variation of proteins and metabolites in CSF of neurologically normal individuals appears to be essential for reliable interpretation of biomarker discovery studies for CNS disorders because such results may be influenced by natural inter-individual variations. Therefore, proteins and metabolites with high variation between individuals ought to be assessed with caution as candidate biomarkers because at least part of the difference observed between the diseased individuals and the controls will not be caused by the disease, but rather by the natural biological variation between individuals.

National Category
Natural Sciences
Identifiers
urn:nbn:se:uu:diva-162115 (URN)10.1074/mcp.M900877-MCP200 (DOI)20811074 (PubMedID)
Available from: 2011-11-24 Created: 2011-11-24 Last updated: 2017-12-08
Rosenling, T., Slim, C. L., Christin, C., Coulier, L., Shi, S., Stoop, M. P., . . . Bischoff, R. (2009). The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).. Journal of Proteome Research, 8(12), 5511-22
Open this publication in new window or tab >>The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
Show others...
2009 (English)In: Journal of Proteome Research, ISSN 1535-3893, E-ISSN 1535-3907, Vol. 8, no 12, p. 5511-22Article in journal (Refereed) Published
Abstract [en]

To standardize the use of cerebrospinal fluid (CSF) for biomarker research, a set of stability studies have been performed on porcine samples to investigate the influence of common sample handling procedures on proteins, peptides, metabolites and free amino acids. This study focuses at the effect on proteins and peptides, analyzed by applying label-free quantitation using microfluidics nanoscale liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (chipLC-MS) as well as matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI-FT-ICR-MS) and Orbitrap LC-MS/MS to trypsin-digested CSF samples. The factors assessed were a 30 or 120 min time delay at room temperature before storage at -80 degrees C after the collection of CSF in order to mimic potential delays in the clinic (delayed storage), storage at 4 degrees C after trypsin digestion to mimic the time that samples remain in the cooled autosampler of the analyzer, and repeated freeze-thaw cycles to mimic storage and handling procedures in the laboratory. The delayed storage factor was also analyzed by gas chromatography mass spectrometry (GC-MS) and liquid chromatography mass spectrometry (LC-MS) for changes of metabolites and free amino acids, respectively. Our results show that repeated freeze/thawing introduced changes in transthyretin peptide levels. The trypsin digested samples left at 4 degrees C in the autosampler showed a time-dependent decrease of peak areas for peptides from prostaglandin D-synthase and serotransferrin. Delayed storage of CSF led to changes in prostaglandin D-synthase derived peptides as well as to increased levels of certain amino acids and metabolites. The changes of metabolites, amino acids and proteins in the delayed storage study appear to be related to remaining white blood cells. Our recommendations are to centrifuge CSF samples immediately after collection to remove white blood cells, aliquot, and then snap-freeze the supernatant in liquid nitrogen for storage at -80 degrees C. Preferably samples should not be left in the autosampler for more than 24 h and freeze/thaw cycles should be avoided if at all possible.

National Category
Natural Sciences
Identifiers
urn:nbn:se:uu:diva-162116 (URN)10.1021/pr9005876 (DOI)19845411 (PubMedID)
Available from: 2011-11-24 Created: 2011-11-24 Last updated: 2017-12-08
Jönsson, M., Qvarnström, Y., Rosenling, T. & Swedberg, G.Further characterisation of the bifunctional HPPK-DHPS from Plasmodium falciparum.
Open this publication in new window or tab >>Further characterisation of the bifunctional HPPK-DHPS from Plasmodium falciparum
(English)Manuscript (Other academic)
Identifiers
urn:nbn:se:uu:diva-93135 (URN)
Available from: 2005-05-13 Created: 2005-05-13 Last updated: 2011-11-24
Organisations

Search in DiVA

Show all publications